Color的动态

#DidYouKnow that Cervical Cancer (CC) is the 8th most diagnosed and 9th leading cause of cancer mortality in the world? With over 660,000 new cases and almost 350,000 deaths in 2022, cervical cancer remains a significant global health issue, particularly in regions like Asia and Africa. Early detection, vaccination, and screening remain crucial in curbing these numbers. Since 2019, more than 1,300 clinical trials have been initiated globally, with the Asia-Pacific region leading in trial activity. Novotech’s comprehensive report on Cervical Cancer provides a thorough analysis of the current treatment landscape and research developments in this field, while also highlighting existing and projected trends in funding and research efforts related to Cervical Cancer. Download this free report https://lnkd.in/dRFp8fcp #CervicalCancer #ClinicalTrials #OncologyResearch

Breast cancer is the most commonly diagnosed cancer among women in Kenya, contributing to nearly 20% of all new cancer cases. According to the Kenya National Cancer Screening Guidelines (2022), breast cancer cases have been increasing steadily over the years. The Kenya Cancer Registry estimated that in 2020, there were around 6,799 new cases of breast cancer in the country, with nearly 3,107 deaths attributed to the disease. The Kenya Medical Research Institute (KEMRI) further reported that 1 in 9 women in Kenya is at risk of developing breast cancer during their lifetime. Key Statistics: Breast cancer prevalence: Around 6,799 new cases (2020). Mortality rate: Nearly 45% of patients die due to late diagnosis and limited treatment access. At-risk population: 1 in 9 women. Stage of diagnosis: Approximately 70% of breast cancer cases are diagnosed at advanced stages (stage 3 or 4), making treatment less effective and more expensive. Sfx make up@otieno_dennis_254 Model @mary_yala Assistant photographer @akingstone_ke Director @mrsotieno_254 ?? https://lnkd.in/dH4uvUBu #spartanphotography #spartansneverdissapoint #spartanphotographykenya #humanitarianphotography #conceptualphotograpy #journalism #photojournalism #photography

For Lung Cancer Awareness Month, we're revisiting groundbreaking insights on lung cancer types made possible by Forian’s advanced data integration capabilities. Traditional claims data often lacks the detail needed to distinguish between Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC). However, by integrating claims with EHR data, Forian's algorithms accurately classify lung cancer types, enabling a more granular understanding of patient demographics. In our recent analysis, we identified 18,000 patients with lung cancer codes in claims data, with EHR data indicating 65% NSCLC and 35% SCLC. Findings reveal NSCLC patients are more likely to be over 65, while SCLC shows a higher prevalence among women. Forian's integrated approach advances lung cancer research, empowering researchers and healthcare providers with the insights needed to drive improved patient outcomes. #LungCancerAwarenessMonth #LungCancer #DataIntegration #HEOR #RWE #RWD #Forian

#AI is revolutionizing cancer care – in more ways than you might think. #LungCancer is very often diagnosed at later stages when it’s harder to treat. But what if AI can help radiologists detect potentially cancerous nodules earlier? When cancer is found at an earlier stage, patients have more treatment options and a greater chance of survival. DeepHealth’s AI-powered solution is being used to assist radiologists in one of the world’s largest lung cancer screening efforts, the NHS England’s Targeted Lung Check Program, where data from the UK government shows 76% of cancers detected were found at earlier stages. The #RewritingCancer series presented by the Union for International Cancer Control (UICC) and produced for them by BBC StoryWorks explores innovative solutions for cancer prevention, diagnosis, treatment, and care and spotlights DeepHealth’s role in transforming lung cancer screening. Be part of the #RewritingCancer conversation and learn more about our AI-powered solutions that are empowering breakthroughs in cancer screening: https://lnkd.in/evYC_5uW #RewritingCancer #LungCancerScreening #aihealthcare #aiinradiology #healthinformatics #RadiologyWorkflow #TLHC #DeepHealth

Social deprivation should be the governments biggest priority: so sad to read yet another report that highlights that women diagnosed with breast cancer in deprived regions are more likely to get a second non-related cancer. Great work by University of Cambridge for highlighting this, now for some policies to help address it..... https://lnkd.in/ebm5Jn3F #socialdeprivation #healthinequalities

How lessons from C/Can’s global network of cities can support the EU Mission on Cancer’s objectives City Cancer Challenge ECHoS | Establishing of Cancer Mission Hubs: Networks and Synergies #OncoDaily #Oncology #Cancer #Health #Medicine #HealthCare #CancerSupport

By 2050, cancer cases and deaths were projected to increase by 84.3% (to 19 million) and 93.2% (to 10.5 million), respectively. The increase from 2022 to 2050 was more than twofold higher for older men. In 2022, the estimated global cancer mortality-to-incidence ratios (MIRs) among men was nearly 55%, with variations by cancer types, age, and HDI. The MIR was lowest for?thyroid cancer?(7.6%) and highest for?pancreatic cancer?(90.9%)

Long-term and Very Long-term Cancer Survivors Represent a Large and Increasing Proportion of the U.S. Population. This work ???? is crucial for cancer survivors, especially #AYAs who can live for decades. It's encouraging to see the National Cancer Institute (NCI) Office of Cancer Survivorship, under the leadership of Dr. Emily Tonorezos, raising awareness for research to improve the lives to be lived for those beyond their diagnosis. #cancer #cancersurvivorship #cansurv #AYACSM #Lateandlongterm https://lnkd.in/g_WbCSxj

We were proud to join the American Cancer Society (ACS), Prostate Health Education Network, ZERO Prostate Cancer and other leaders across the Oncology community for the launch of the National Prostate Cancer Roundtable https://lnkd.in/eEVbw9Jv, a coalition of organizations dedicated to a shared vision of improving prostate cancer outcomes and survivorship for all through increasing awareness and equitable access to prevention, screening and treatment. Prostate cancer is the second most common cancer among men in the United States, with about 1 in 8 men facing a diagnosis in their lifetime. Black men are not only more likely to be diagnosed with prostate cancer, but are also twice as likely to die from the disease than other racial or ethnic groups. At Pfizer, we believe in the power of collaboration and partnership to drive meaningful change. Through our sponsorship of the National Prostate Cancer Roundtable as well as other collaborative efforts with the community, such as our Change the Odds? https://lnkd.in/eM9ApeDa initiative with ACS and support for PHEN's Prostate Cancer Disparity Rally https://lnkd.in/emPTvCr2, we are dedicated to addressing these disparities and improving cancer outcomes for all. #ProstateCancerAwarenessMonth #HealthEquity #CancerCare #ChangeTheOdds #ProstateCancer

Every 14 seconds, somewhere in the world, a woman is diagnosed with breast cancer… Making it the second most common cancer in the world, according to the Breast Cancer Research Foundation. Early detection literally saves lives. This makes the validity of having an annual Breast Cancer awareness month, held in October, extremely obvious. At LOGEX, we also see Breast Cancer Awareness Month as an important time to reflect on the challenges and advancements in the treatment of patients with breast cancer. Our focus is on leveraging real-world data and analytics. Through collaborations with healthcare providers, researchers, life science companies and patient organisations, we aim to increase the understanding of how care is being provided internationally and how optimisation is possible in order to achieve more positive outcomes at a faster pace for patients. Thu ultimate goal is to reduce the impact of breast cancer on patients and their families. Two examples of our work in this field: 1-?Should breast cancer patients suffer from heartburn to not temper with the effectiveness of their cancer treatment, as is suggested by literature? Our real-world data research implies that the answer is ‘no’: Proton pump inhibitors help reduce heartburn and their use does not show a negative effect on the effectiveness of the cancer treatment: https://lnkd.in/eH6mZd5k. 2- The outcomes of the treatment of breast cancer varies quite significantly, even when looking at just European countries. There are important knowledge gaps in our understanding of how these variations can be explained. LOGEX worked with researchers and hospitals across Europe to gather and analyse real-world data on care paths in different countries, leading to some highly relevant insights and best practices https://lnkd.in/eD-MkV4M. Curious to learn more about how we try to turn data into better healthcare? Visit logex.com. Esther Dronkers,Esmée van Geffen,Naomi de Kruif,Nicole Kerklaan,Femke Oldenziel,Jan van der Eijk,Pieter Krop,Shannen van Duijn,Zelda Odé,Lia Lapian #LOGEX #BreastCancerAwareness #BCAM2024 #EarlyDetectionSavesLives #BreastCancerResearch #FightBreastCancer #HopeForACure #StrongerTogether #RealWorldData #DataForGood #HealthcareInnovation #PatientCare #LOGEXCares #SupportTheCause #PinkRibbonMonth